Parmax Pharma Shareholding Pattern

As of Sept 2025, Parmax Pharma (PARMAX) promoter holding 30.80%, FII 0.00%, DII 0.00%, public 63.09%, total shareholders 2,399. For live price, key ratios and the full company profile, see Parmax Pharma stock price NSE .

Promoter Holding 30.80%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 63.09%
Total Shareholders 2,399
As of Sept 2025

PARMAX Recent Shareholding Changes — Promoter, FII & DII

Parmax Pharma promoter, FII and DII holding change from Jun 2025 to Sept 2025. Compare with PARMAX DCF to assess whether the stock is under or overvalued.

Promoter Holding Change
Jun 2025 to Sept 2025
No Change
FII Holding Change
Jun 2025 to Sept 2025
No Change
DII Holding Change
Jun 2025 to Sept 2025
No Change
Public Holding Change
Jun 2025 to Sept 2025
-0.01%

Parmax Pharma Quarterly Shareholding Trend — Promoter, FII, DII & Public

PARMAX promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Review PARMAX price earnings ratio to evaluate earnings-based valuation against sector peers.

Promoter
FII
DII
Public
Government

PARMAX Shareholding Pattern Data — Quarterly History

Parmax Pharma quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 30.80% 0.00% 0.00% 0.00% 63.09% 6.11% 100.00% 2,399
Jun 2025 30.80% 0.00% 0.00% 0.00% 63.10% 6.10% 100.00% 2,377
Mar 2025 30.80% 0.00% 0.00% 0.00% 63.10% 6.10% 100.00% 2,356
Dec 2024 30.80% 0.00% 0.00% 0.00% 63.12% 6.08% 100.00% 2,334
Sept 2024 30.80% 0.00% 0.00% 0.00% 62.90% 6.29% 99.99% 2,246
Jun 2024 30.80% 0.00% 0.00% 0.00% 65.78% 3.42% 100.00% 2,185
Mar 2024 30.83% 0.00% 0.00% 0.00% 65.34% 3.83% 100.00% 2,099
Dec 2023 30.80% 0.00% 0.00% 0.00% 65.43% 3.77% 100.00% 2,002
Sept 2023 30.80% 0.00% 0.00% 0.00% 65.43% 3.76% 99.99% 1,973
Jun 2023 30.80% 0.00% 0.00% 0.00% 65.42% 3.78% 100.00% 1,978
Mar 2023 30.80% 0.00% 0.00% 0.00% 65.38% 3.81% 99.99% 1,997
Dec 2022 30.80% 0.00% 0.00% 0.00% 65.36% 3.84% 100.00% 101,650
Sept 2022 30.80% 0.00% 0.00% 0.00% 65.37% 3.83% 100.00% 1,590
Jun 2022 30.80% 0.00% 0.00% 0.00% 68.00% 1.20% 100.00% 1,551
Mar 2022 30.80% 0.00% 0.00% 0.00% 68.01% 1.19% 100.00% 1,526
Dec 2021 30.80% 0.00% 0.00% 0.00% 67.98% 1.22% 100.00% 1,344
Sept 2021 30.80% 0.00% 0.00% 0.00% 67.93% 1.27% 100.00% 1,188
Jun 2021 30.80% 0.00% 0.00% 0.00% 68.03% 1.17% 100.00% 928
Mar 2021 30.80% 0.00% 0.00% 0.00% 68.09% 1.10% 99.99% 0
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 30.80% 0.00% 0.00% 0.00% 63.09% 6.11% 100.00% 2,399
Jun 2025 30.80% 0.00% 0.00% 0.00% 63.10% 6.10% 100.00% 2,377
Mar 2025 30.80% 0.00% 0.00% 0.00% 63.10% 6.10% 100.00% 2,356
Dec 2024 30.80% 0.00% 0.00% 0.00% 63.12% 6.08% 100.00% 2,334
Sept 2024 30.80% 0.00% 0.00% 0.00% 62.90% 6.29% 99.99% 2,246
Jun 2024 30.80% 0.00% 0.00% 0.00% 65.78% 3.42% 100.00% 2,185
Mar 2024 30.83% 0.00% 0.00% 0.00% 65.34% 3.83% 100.00% 2,099
Dec 2023 30.80% 0.00% 0.00% 0.00% 65.43% 3.77% 100.00% 2,002
Sept 2023 30.80% 0.00% 0.00% 0.00% 65.43% 3.76% 99.99% 1,973
Jun 2023 30.80% 0.00% 0.00% 0.00% 65.42% 3.78% 100.00% 1,978
Mar 2023 30.80% 0.00% 0.00% 0.00% 65.38% 3.81% 99.99% 1,997
Dec 2022 30.80% 0.00% 0.00% 0.00% 65.36% 3.84% 100.00% 101,650
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2025 30.80% 0.00% 0.00% 0.00% 63.10% 6.10% 100.00% 2,356
Dec 2024 30.80% 0.00% 0.00% 0.00% 63.12% 6.08% 100.00% 2,334
Dec 2023 30.80% 0.00% 0.00% 0.00% 65.43% 3.77% 100.00% 2,002
Dec 2022 30.80% 0.00% 0.00% 0.00% 65.36% 3.84% 100.00% 101,650
Dec 2021 30.80% 0.00% 0.00% 0.00% 67.98% 1.22% 100.00% 1,344